News articles about Neogen (NASDAQ:NEOG) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neogen earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.5604270631459 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the news stories that may have effected Accern Sentiment’s rankings:
- Neogen Corporation :NEOG-US: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 (finance.yahoo.com)
- Positive Market Trends Aid Cardiovascular Systems Amid Woes (finance.yahoo.com)
- Head to Head Contrast: NuVasive (NUVA) and Neogen (NEOG) (americanbankingnews.com)
- Free Post Earnings Research Report: Neogen Reported Record Breaking Revenue and Earnings (finance.yahoo.com)
- Neogen Co. (NEOG) Expected to Announce Quarterly Sales of $97.28 Million (americanbankingnews.com)
A number of analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Neogen from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Roth Capital initiated coverage on shares of Neogen in a report on Tuesday, December 5th. They issued a “neutral” rating and a $61.50 target price on the stock. Craig Hallum boosted their target price on shares of Neogen from $46.50 to $60.00 and gave the stock a “hold” rating in a report on Thursday, December 7th. Stephens restated a “hold” rating and issued a $62.00 target price on shares of Neogen in a report on Wednesday, January 10th. Finally, BidaskClub downgraded shares of Neogen from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Five analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $63.25.
Shares of Neogen (NEOG) opened at $58.91 on Friday. The stock has a market cap of $2,991.40, a PE ratio of 57.77, a price-to-earnings-growth ratio of 3.66 and a beta of 1.54. Neogen has a 52-week low of $44.63 and a 52-week high of $64.42.
Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Wednesday, January 3rd. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.07. Neogen had a net margin of 13.47% and a return on equity of 10.72%. The company had revenue of $101.80 million during the quarter, compared to analysts’ expectations of $102.46 million. During the same period in the previous year, the company earned $0.29 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. analysts anticipate that Neogen will post 1.06 EPS for the current year.
In related news, VP Edward Bradley sold 17,824 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $80.32, for a total transaction of $1,431,623.68. Following the completion of the transaction, the vice president now owns 27,212 shares in the company, valued at approximately $2,185,667.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Steven J. Quinlan sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $80.26, for a total transaction of $321,040.00. Following the transaction, the chief financial officer now owns 14,103 shares of the company’s stock, valued at approximately $1,131,906.78. The disclosure for this sale can be found here. Insiders sold a total of 47,824 shares of company stock valued at $3,870,364 in the last ninety days. Corporate insiders own 4.20% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.thelincolnianonline.com/2018/01/20/neogen-neog-earning-somewhat-favorable-press-coverage-analysis-finds-updated-updated-updated.html.
Neogen Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Neogen and related companies with MarketBeat.com’s FREE daily email newsletter.